Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

Published on Aug 1, 2019in International Journal of Cancer5.145
· DOI :10.1002/IJC.32127
Ofure Obazee9
Estimated H-index: 9
(DKFZ: German Cancer Research Center),
Livia Archibugi13
Estimated H-index: 13
+ 58 AuthorsFederico Canzian82
Estimated H-index: 82
(DKFZ: German Cancer Research Center)
: Rare truncating BRCA2 K3326X (rs11571833) and pathogenic CHEK2 I157T (rs17879961) variants have previously been implicated in familial pancreatic ductal adenocarcinoma (PDAC), but not in sporadic cases. The effect of both mutations in important DNA repair genes on sporadic PDAC risk may shed light on the genetic architecture of this disease. Both mutations were genotyped in germline DNA from 2,935 sporadic PDAC cases and 5,626 control subjects within the PANcreatic Disease ReseArch (PANDoRA) consortium. Risk estimates were evaluated using multivariate unconditional logistic regression with adjustment for possible confounders such as sex, age and country of origin. Statistical analyses were two-sided with p values <0.05 considered significant. K3326X and I157T were associated with increased risk of developing sporadic PDAC (odds ratio (ORdom ) = 1.78, 95% confidence interval (CI) = 1.26-2.52, p = 1.19 × 10-3 and ORdom = 1.74, 95% CI = 1.15-2.63, p = 8.57 × 10-3 , respectively). Neither mutation was significantly associated with risk of developing early-onset PDAC. This retrospective study demonstrates novel risk estimates of K3326X and I157T in sporadic PDAC which suggest that upon validation and in combination with other established genetic and non-genetic risk factors, these mutations may be used to improve pancreatic cancer risk assessment in European populations. Identification of carriers of these risk alleles as high-risk groups may also facilitate screening or prevention strategies for such individuals, regardless of family history.
📖 Papers frequently viewed together
9 Citations
19 Citations
#1Chunling Hu (Mayo Clinic)H-Index: 25
#1Chunling Hu (Mayo Clinic)H-Index: 10
Last. Fergus J. Couch (Mayo Clinic)H-Index: 115
view all 19 authors...
Importance Individuals genetically predisposed to pancreatic cancer may benefit from early detection. Genes that predispose to pancreatic cancer and the risks of pancreatic cancer associated with mutations in these genes are not well defined. Objective To determine whether inherited germline mutations in cancer predisposition genes are associated with increased risks of pancreatic cancer. Design, Setting, and Participants Case-control analysis to identify pancreatic cancer predisposition genes; ...
161 CitationsSource
#1Alison P. Klein (Johns Hopkins University)H-Index: 67
#2Brian M. Wolpin (Harvard University)H-Index: 64
Last. Laufey T. Amundadottir (Johns Hopkins University)H-Index: 48
view all 123 authors...
In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic canc ...
96 CitationsSource
#1Marcin Lener (Pomeranian Medical University)H-Index: 19
#2Aniruddh Kashyap (Pomeranian Medical University)H-Index: 11
Last. Jan Lubinski (Pomeranian Medical University)H-Index: 112
view all 9 authors...
Familial pancreatic cancer describes families with at least two first-degree relatives with pancreatic cancer that do not fulfil the criteria of other inherited tumor syndromes with increased risks of pancreatic cancer. Although much has been learned regarding the aggregation of pancreatic cancer in some families, the genetic basis for this familial aggregation is poorly understood. This study evaluated the prevalence of 10 Polish founder mutations in four genes among individuals from families w...
11 CitationsSource
#1Christopher I. Amos (Dartmouth College)H-Index: 132
#2Joe Dennis (University of Cambridge)H-Index: 55
Last. Douglas F. Easton (University of Cambridge)H-Index: 172
view all 93 authors...
Background:Common cancers develop through a multistep process often including inherited susceptibility. Collaboration among multiple institutions, and funding from multiple sources, has allowed the development of an inexpensive genotyping microarray, the OncoArray. The array includes a genome-wide backbone, comprising 230,000 SNPs tagging most common genetic variants, together with dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers a...
187 CitationsSource
8 CitationsSource
#1Louis de MestierH-Index: 17
Last. Pascal HammelH-Index: 86
view all 7 authors...
Germline BRCA2 mutations are the first known cause of inherited (familial) pancreatic ductal adenocarcinoma (PDAC). This tumor is the third most frequent cancer in carriers of germline BRCA2 mutations, as it occurs in around 10% of BRCA2 families. PDAC is known as one of the most highly lethal cancers, mainly because of its chemoresistance and frequently late diagnosis. Based on recent developments in molecular biology, a subgroup of BRCA2-associated PDAC has been created, allowing screening, ea...
12 CitationsSource
#1Yuqiu Ge (Nanjing Medical University)H-Index: 9
#2Yunyan Wang (Nanjing Medical University)H-Index: 3
Last. Zhengdong Zhang (Nanjing Medical University)H-Index: 52
view all 9 authors...
Previous studies have shown that two rare variants, rs11571833 in BRCA2 and rs17879961 in CHEK2 were associated with lung cancer. However, the associations between these two variants and urinary tract cancers risk remain largely unexplored. We applied imputation of three genome-wide association studies published in the database of Genotypes and Phenotypes (dbGaP). Unconditional logistic regression analysis and meta-analysis were performed to assess the association between these two variants and ...
12 CitationsSource
#1Huong Meeks (UofU: University of Utah)H-Index: 8
#2Honglin Song (University of Cambridge)H-Index: 48
Last. David E. Goldgar (UofU: University of Utah)H-Index: 110
view all 253 authors...
Background: The K3326X variant in BRCA2 (BRCA2*c.9976A>T; p.Lys3326*; rs11571833) has been found to be associated with small increased risks of breast cancer. However, it is not clear to what extent linkage disequilibrium with fully pathogenic mutations might account for this association. There is scant information about the effect of K3326X in other hormone-related cancers. Methods: Using weighted logistic regression, we analyzed data from the large iCOGS study including 76 637 cancer case pati...
62 CitationsSource
Although relatively rare, pancreatic tumors are highly lethal [1]. In the United States, an estimated 48,960 individuals will be diagnosed with pancreatic cancer and 40,560 will die from this disease in 2015 [1]. Globally, 337,872 new pancreatic cancer cases and 330,391 deaths were estimated in 2012 [2]. In contrast to most other cancers, mortality rates for pancreatic cancer are not improving; in the US, it is predicted to become the second leading cause of cancer related deaths by 2030 [3, 4]....
64 CitationsSource
#1Jenny Higgs (University of Manchester)H-Index: 7
#2Elaine F. Harkness (University of Manchester)H-Index: 32
Last. D G R Evans (University of Manchester)H-Index: 63
view all 8 authors...
Background Despite classification of the BRCA2 c.9976A>T, p.(Lys3326Ter) variant as a polymorphism, it has been associated with increased risks of pancreatic, lung, oesophageal and breast cancer. Methods We have noticed multiple co-occurrences of the BRCA2 c.9976A>T variant with the pathogenic BRCA2 c.6275_6276delTT frameshift mutation p.(Leu2092ProfsTer7) and using a cohort study have assessed if this might account for these tumour risk associations. Results We identified 52 families with BRCA2...
9 CitationsSource
Cited By11
#1Manuel Gentiluomo (UniPi: University of Pisa)H-Index: 6
#2C. Corradi (UniPi: University of Pisa)H-Index: 1
Last. Gabriele Capurso (UniSR: Vita-Salute San Raffaele University)H-Index: 56
view all 31 authors...
Although pancreatic ductal adenocarcinoma (PDAC) survival is poor, there are differences in patients' response to the treatments. Detection of predictive biomarkers explaining these differences is of the utmost importance. In a recent study two genetic markers (CD44-rs353630 and CHI3L2-rs684559) were reported to be associated with survival after PDAC resection. We attempted to replicate the associations in 1856 PDAC patients (685 resected with stage I/II) from the PANcreatic Disease ReseArch (PA...
#1Henriett ButzH-Index: 15
#2János Papp (MTA: Hungarian Academy of Sciences)H-Index: 1
Last. Attila PatócsH-Index: 34
view all 7 authors...
The clinical relevance of the BRCA2 C-terminal stop codon variants is controversial. The pathogenic role of the germline BRCA2 c.9976A>T and c.10095delinsGAATTATATCT variants in hereditary breast and ovarian cancer (HBOC) patients was evaluated. An association with clinicopathological parameters was performed in 2491 independent probands diagnosed with HBOC and in 122,209 cancer patients reported earlier. Loss-of-heterozygosity (LOH) in tumor samples and allelic imbalance in RNA extracted from p...
1 CitationsSource
#1Scott L Baughan (WSU: Wayne State University)H-Index: 1
#2Michael A. Tainsky (WSU: Wayne State University)H-Index: 57
Whole genome analysis and the search for mutations in germline and tumor DNAs is becoming a major tool in the evaluation of risk as well as the management of hereditary cancer syndromes. Because of the identification of cancer predisposition gene panels, thousands of such variants have been catalogued yet many remain unclassified, presenting a clinical challenge for the management of hereditary cancer syndromes. Although algorithms exist to estimate the likelihood of a variant being deleterious,...
2 CitationsSource
#1Elena FountzilasH-Index: 5
#1Elena FountzilasH-Index: 14
Last. Philippos C. PatsalisH-Index: 25
view all 35 authors...
Our aim was to determine the prevalence, prognostic and predictive role of germline pathogenic/likely pathogenic variants (P/LPVs) in cancer predisposing genes in patients with pancreatic ductal adenocarcinoma (PDAC). Germline testing of 62 cancer susceptibility genes was performed on unselected patients diagnosed from 02/2003 to 01/2020 with PDAC, treated at Hellenic Cooperative Oncology Group (HeCOG)-affiliated Centers. The main endpoints were prevalence of P/LPVs and overall survival (OS). P/...
#1Lenka Stolarova (First Faculty of Medicine, Charles University in Prague)H-Index: 2
#1Lenka StolarovaH-Index: 5
Last. Zdenek KleiblH-Index: 19
view all 7 authors...
Germline alterations in many genes coding for proteins regulating DNA repair and DNA damage response (DDR) to DNA double-strand breaks (DDSB) have been recognized as pathogenic factors in hereditary cancer predisposition. The ATM-CHEK2-p53 axis has been documented as a backbone for DDR and hypothesized as a barrier against cancer initiation. However, although CHK2 kinase coded by the CHEK2 gene expedites the DDR signal, its function in activation of p53-dependent cell cycle arrest is dispensable...
6 CitationsSource
#1Haijie Hu (Sichuan University)H-Index: 2
#2Yayun Zhu (Fudan University)H-Index: 3
Last. Jun Yu (Johns Hopkins University)H-Index: 154
view all 10 authors...
ABSTRACT Backgroud The frequency and significance of the germline variants in DNA damage repair genes still need to be elucidated in patients with sporadic pancreatic ductal adenocarcinoma (PDAC). Our purpose was to determine whether germline variants in DNA damage repair genes were associated with survival of patients with sporadic PDAC. Study Design We retrospectively identified 854 patients with sporadic PDAC with germline DNA sequenced in targeted 22 DNA damage repair genes by next-generatio...
1 CitationsSource
#1Manuel Gentiluomo (UniPi: University of Pisa)H-Index: 6
#2Federico Canzian (DKFZ: German Cancer Research Center)H-Index: 82
Last. Daniele Campa (UniPi: University of Pisa)H-Index: 34
view all 6 authors...
Pancreatic cancer (PC), particularly its most common form, pancreatic ductal adenocarcinoma (PDAC), is relatively rare but highly lethal. Knowledge about PC risk factors could in the long term contribute to early diagnosis and mortality reduction. We review the current status of research on germline genetic factors for PC risk. Genome-wide association studies (GWAS) successfully identified common loci convincingly associated with PC risk, an endeavor that is still ongoing. The function of only a...
3 CitationsSource
#1Shannon R. Nelson (DCU: Dublin City University)H-Index: 1
#2Naomi Walsh (DCU: Dublin City University)H-Index: 13
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death worldwide. This high mortality rate is due to the disease’s lack of symptoms, resulting in a late diagnosis. Biomarkers and treatment options for pancreatic cancer are also limited. In order to overcome this, new research models and novel approaches to discovering PDAC biomarkers are required. In this review, we outline the hereditary and somatic causes of PDAC and provide an overview of the recent genome...
1 CitationsSource
#1Ines Lohse (UM: University of Miami)H-Index: 15
Pancreatic cancer is often diagnosed due to the patient seeking medical attention for abdominal pain. It is among the most painful cancers, with pain severity strongly correlating with prognosis. Perineural invasion is a prominent feature of pancreatic cancer and often the first route of metastasis resulting in neuropathic pain. While surgical pain is present, it is generally short-lived; chemo- and radio-therapy associated side effect pain is often longer lasting and more difficult to manage. T...
8 CitationsSource
#1Manuel Gentiluomo (UniPi: University of Pisa)H-Index: 6
#2Giulia Peduzzi (UniPi: University of Pisa)H-Index: 1
Last. Federico Canzian (DKFZ: German Cancer Research Center)H-Index: 82
view all 5 authors...
There is overwhelming evidence that inflammation plays a key role in the pathogenesis of cancer and its progression. Inflammation is regulated through a complex network of genes and polymorphic variants in these genes have been found to be associated to risk of various human cancers, alone or in combination with environmental variables. Despite this, not much is known on the genetic variability of genes that regulate inflammation and risk of pancreatic ductal adenocarcinoma (PDAC). We performed ...
4 CitationsSource